Cassava Sciences Inc (SAVA)

[runncoach]

I had researched them in the past. In theory I liked their story about synaptic health and how the drug potentially worked. Preclinical it had a secondary impact on PKCe and Hgf and as you know, this is something I have researched. When I looked at details of how they were running their clinical trials I had concerns about the memantine free period before dosing so have never bought in. I still think they have a shot but maybe longer than I first thought. Of course at current prices it may be a better gamble than in the past.

I still follow the sector but I'm just not seeing a revolutionary treatment at this time. Doesn't mean none of these will have limited success, or potential approvals in some groups, or nice sales, or even make shareholders good money. I've been hoping for a true game changer and I don't currently see one. JMHO